EGFR and breast cancer: Diosgenin increases the phosphorylation level of JNK to inhibit the proliferation of the breast cancer cells with a high expression of human epidermal growth factor receptor and to promote cell apoptosis, possibly by inhibiting Akt and mTOR phosphorylation [35].